Enhancers of KCNQ channels are known to be effective in chronic pain models. To discover novel enhancers of KCNQ channels, the authors developed a medium-throughput electrophysiological assay by using the IonWorks platform. Screening of 20 CHO-K1 clones stably expressing KCNQ2/3 was performed on the IonWorks HT until the best clone (judged from seal rate, current level, and stability) was obtained. The KCNQ2/3 current amplitude in the cells was found to increase from 60 ± 15 pA to 473 ± 80 pA (at —10 mV), and the expression rate was increased by 56% when the cells were incubated at 27 °C overnight. The clone used for compound screening had a seal rate of greater than 90% and an overall success rate of greater than 70%. The voltage step protocol (hold cells at —80 mV and depolarize to —10 mV for 1 s) was designed to provide moderate current but still allow for pharmacological current enhancement. EC50s were generated from 8-point concentration-response curves with a control compound on each plate using compounds that were also tested with conventional patch clamp. The authors found that there was a very good correlation (R2 > 0.9) between the 2 assays, thus demonstrating the highly predictive nature of the IonWorks assay. (Journal of Biomolecular Screening 2007;1059-1067)
Loussouarn G. , Park KH, Bellocq C., Baro I., Charpentier F., Escande D.: Phosphatidylinositol-4,5-bisphosphate, PIP2, controls KCNQ1/KCNE1 voltage-gated potassium channels: a functional homology between voltage-gated and inward rectifier K+ channels. EMBO J2003;22:5412-5421.
2.
Suh B-C. , Hille B.: Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis . Neuron2002; 35:507-520.
3.
Zhang H., Craciun LC, Mirshahi T., Rohacs T., Lopes CMB, Jin T., et al: PIP(2) activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of M currents. Neuron2003;37:963-975.
4.
Alaburda A., Perrier J-F., Hounsgaard J.: An M-like outward current regulates the excitability of spinal motoneurones in the adult turtle. J Physiol2002;540:875-881.
5.
Gu N., Vervaeke K., Hu H., Storm JF: Kv7/KCNQ/M and HCN/h, but not KCa2/SK channels, contribute to the somatic medium after-hyperpolarization and excitability control in CA1 hippocampal pyramidal cells. J Physiol2005; 566:689-715.
6.
Rivera-Arconada I., Lopez-Garcia JA: Effects of M-current modulators on the excitability of immature rat spinal sensory and motor neurones. Eur J Neurosci2005;22:3091-3098.
7.
Rivera-Arconada I., Martinez-Gomez J., Lopez-Garcia JA: M-current modulators alter rat spinal nociceptive transmission: an electrophysiological study in vitro. Neuropharmacology2004;46:598-606.
8.
Romero M., Reboreda A., Sanchez E., Lamas JA: Newly developed blockers of the M-current do not reduce spike frequency adaptation in cultured mouse sympathetic neurons. Eur J Neurosci2004;19:2693-2702.
9.
Main MJ, Cryan JE, Dupere JR, Cox B., Clare JJ, Burbidge SA: Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine . Mol Pharmacol2000;58:253-262.
10.
Rundfeldt C. , Netzer R.: The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells transfected with human KCNQ2/3 subunits . Neurosci Lett2000;282:73-76.
11.
Wickenden AD , Yu W., Zou A., Jegla T., Wagoner PK: Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels . Mol Pharmacol2000;58:591-600.
12.
Dupuis DS, Schroder RL, Jespersen T., Christensen JK, Christophersen P., Jensen BS, et al: Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352. Eur J Pharmacol2002;437:129-137.
13.
Schroder RL , Jespersen T., Christophersen P., Strobaek D., Jensen BS, Olesen SP: KCNQ4 channel activation by BMS-204352 and retigabine [published correction appears in Neuropharmacology. 2003;44(4):553]. Neuropharmacology2001;40:888-898.
14.
Schroder RL , Strobaek D., Olesen S-P., Christophersen P.: Voltage-independent KCNQ4 currents induced by (+/—)BMS-204352. Pflugers Arch2003;446:607-616.
15.
Hetka R., Rundfeldt C., Heinemann U., Schmitz D.: Retigabine strongly reduces repetitive firing in rat entorhinal cortex . Eur J Pharmacol1999;386:165-171.
16.
Yue C., Yaari Y.: KCNQ/M channels control spike afterdepolarization and burst generation in hippocampal neurons. J Neurosci2004;24:4614-4624.
17.
Blackburn-Munro G., Dalby-Brown W., Mirza NR, Mikkelsen JD, Blackburn-Munro RE: Retigabine: chemical synthesis to clinical application. CNS Drug Rev2005;11:1-20.
18.
Blackburn-Munro G., Jensen BS: The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain. Eur J Pharmacol2003;460:109-116.
19.
Dost R., Rostock A., Rundfeldt C.: The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation. Naunyn-Schmiedebergs Arch Pharmacol2004;369:382-390.
20.
Passmore GM , Selyanko AA, Mistry M., Al-Qatari M., Marsh SJ, Matthews EA, et al: KCNQ/M currents in sensory neurons: significance for pain therapy. J Neurosci2003;23:7227-7236.
21.
Bridgland-Taylor MH, Hargreaves AC, Easter A., Orme A., Henthorn DC, Ding M., et al: Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks™ HT. J Pharmacol Toxicol Methods2006;54:189-199.
22.
Guthrie H., Livingston FS, Gubler U., Garippa R.: A place for high-throughput electrophysiology in cardiac safety: screening hERG cell lines and novel compounds with the IonWorks HT™ system. J Biomol Screen2005;10:832-840.
23.
Sorota S., Zhang X-S., Margulis M., Tucker K., Priestley T.: Characterization of a hERG screen using the IonWorks HT: comparison to a hERG rubidium efflux screen. Assay Drug Dev Technol2005;3:47-57.
24.
John VH, Dale TJ, Hollands EC, Chen MX, Partington L., Downie DL, et al: Novel 384-well population patch clamp electrophysiology assays for Ca2+-activated K+ channels. J Biomol Screen2007;12:50-60.
25.
Schroeder K. , Neagle B., Trezise DJ, Worley J.: Ionworks HT: a new high-throughput electrophysiology measurement platform . J Biomol Screen2003 ;8:50-64.
26.
Tatulian L. , Brown DA: Effect of the KCNQ potassium channel opener retigabine on single KCNQ2/3 channels expressed in CHO cells. J Physiol2003;549:57-63.
27.
Wang H-S., Pan Z., Shi W., Brown BS, Wymore RS, Cohen IS, et al: KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science1998;282:1890-1893.
28.
Wang K., McIlvain B., Tseng E., Kowal D., Jow F., Shen R., et al: Validation of an atomic absorption rubidium ion efflux assay for KCNQ/M-channels using the ion Channel Reader 8000. Assay Drug Dev Technol2004;2:525-534.
29.
Molecular adsorption to polypropylene compound plate may reduce potency measurements. Retrieved from http://www.moleculardevices.com/pages/instruments/ionworks_techsupport.html.
30.
Armijo JA, Shushtarian M., Valdizan EM, Cuadrado A., de las Cuevas I., Adin J.: Ion channels and epilepsy. Curr Pharm Design2005;11:1975-2003.
31.
Dost R., Rundfeldt C.: The anticonvulsant retigabine potently suppresses epileptiform discharges in the low Ca++ and low Mg++ model in the hippocampal slice preparation. Epilepsy Res2000; 38:53-66.
32.
Gribkoff VK : The therapeutic potential of neuronal KCNQ channel modulators. Expert Opin Ther Targets2003;7:737-748.
33.
Korsgaard Mpg , Hartz BP, Brown WD, Ahring PK, Strobaek D., Mirza NR: Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels . J Pharmacol Exp Ther2005;314:282-292.
34.
Lerche H., Weber YG, Jurkat-Rott K., Lehmann-Horn F.: Ion channel defects in idiopathic epilepsies. Curr Pharm Des2005;11:2737-2752.
35.
Armand V., Rundfeldt C., Heinemann U.: Effects of retigabine (D-23129) on different patterns of epileptiform activity induced by 4-aminopyridine in rat entorhinal cortex hippocampal slices . Naunyn-Schmiedebergs Arch Pharmacol1999 ;359:33-39.
36.
Armand V., Rundfeldt C., Heinemann U.: Effects of retigabine (D-23129) on different patterns of epileptiform activity induced by low magnesium in rat entorhinal cortex hippocampal slices . Epilepsia2000;41:28-33.
37.
Harrison PK , Sheridan RD, Green AC, Tattersall JEH: Effects of anticonvulsants on soman-induced epileptiform activity in the guinea-pig in vitro hippocampus. Eur J Pharmacol2005 ;518:123-132.
38.
Piccinin S. , Randall AD, Brown JT: KCNQ/Kv7 channel regulation of hippocampal gamma-frequency firing in the absence of synaptic transmission . J Neurophysiol2006;95:3105-3112.
39.
Rekling JC: Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation. Neurosci Lett2003;335:167-170.
40.
Straub H., Kohling R., Hohling J., Rundfeldt C., Tuxhorn I., Ebner A., et al: Effects of retigabine on rhythmic synchronous activity of human neocortical slices. Epilepsy Res2001;44:155-165.
